cvl-354
·Code: CVL-354
cvl-354: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Cerevel Therapeutics Holdings, Inc. (CERE) | Phase 1 |
Clinical Trials (1)
A Phase 1, Open-label Trial to Evaluate Target Occupancy of CVL-354 at Kappa Opioid and Mu Opioid Receptors in Brain Following Single Oral Doses in Healthy Participants Using Positron Emission Tomography
Frequently asked questions
Who is developing cvl-354?
cvl-354 is being developed by Cerevel Therapeutics Holdings, Inc..
How many clinical trials involve cvl-354?
BioSniper tracks 1 clinical trial involving cvl-354.
Get deeper analysis on cvl-354
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis